IN8bio cuts staff and pipeline to focus on AML cell therapy

Sep 6, 2024 - 04:00

IN8bio cuts staff and pipeline to focus on AML cell therapy

Read the original article

Tags:

Previous Article

eGenesis scoops $191m for genetically modified pig kidney transplant trial

NHS England offers MSD belzutifan for von Hippel-Lindau disease

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Madrigal seeks expedited approval for NASH treatment

Madrigal seeks expedited approval for NASH treatment

Jul 3, 2023

‘I felt like I was dying’: How women with postpartum depression fall through the cracks of U.S. health care

‘I felt like I was dying’: How women with postpartum de...

Jun 26, 2023

Wegovy can reduce heart failure symptoms in obese patients, study shows

Wegovy can reduce heart failure symptoms in obese patie...

Aug 26, 2023